Occidental Petroleum
OXY
$62.73
-2.09%
Occidental Petroleum is an independent exploration and production company operating across the United States, Latin America, and the Middle East, with net proved reserves of roughly 4.6 billion barrels of oil equivalent and 2025 net production averaging about 1.4 million boe/d at a 74% oil/NGL and 26% natural gas mix, supplemented by a midstream segment and a legacy chemicals business. It is one of the largest pure-play E&P operators in the Permian Basin and is distinguished by its scale, its integrated midstream/OxyChem footprint, and the long-standing strategic backing of Berkshire Hathaway, which has made it a bellwether name for energy-sector sentiment. The current investor narrative centers on deleveraging and portfolio simplification following the roughly $9.7 billion sale of its chemicals unit to Berkshire, which management is using to pay down debt and sharpen the focus on oil and gas, alongside a rare double upgrade from underperform to outperform in July 2026 tied to an improved balance sheet and attractive valuation. That constructive setup is being debated against a Zacks-flagged expectation of a roughly 32% profit decline next year and oil-price sensitivity tied to Middle East geopolitics, leaving investors weighing balance-sheet repair and a 3.97% dividend yield against commodity-cycle earnings risk.…
OXY
Occidental Petroleum
$62.73
Related headlines
Investment Opinion: Should I buy OXY Today?
Rating: Hold. The core thesis is that OXY has substantially repaired its balance sheet through the $9.7 billion chemicals sale and offers an attractive 3.97% dividend yield, but the stock has already rallied 49.65% over the past year and now trades at $64.17 against an average analyst target of $70.54, implying only 9.9% upside. The consensus 'buy' rating (mean 2.19 from 26 analysts) and the July 2026 double upgrade support a constructive view, but the risk/reward is no longer compelling enough for a Buy rating after such a steep run.
Supporting evidence: forward PE of 12.80x is undemanding versus the trailing 24.33x, and the 1.11x price-to-book sits near the low end of its multi-year 1.1-2.1x range. Revenue grew 31.82% YoY in Q2 2026 to $8.327 billion, and TTM free cash flow of $5.312 billion comfortably covers the $430 million quarterly dividend. Debt-to-equity has improved to 0.665 from 0.79 in Q4 2024, and the 3.97% dividend yield is well above the 0.6-1.0% yields seen through 2022-2025. However, trailing net margin of 10.97% and operating margin of 17.24% are modest, and the 67.3% payout ratio limits flexibility.
The biggest risks that could invalidate the thesis are: (1) Zacks' expected 32% profit decline next year, which would challenge the 12.8x forward PE and the $5.23 consensus EPS; (2) a sharp decline in oil prices tied to Middle East geopolitics, which would hit revenue and earnings; and (3) the current ratio of 0.936 signaling tight liquidity. This Hold would upgrade to Buy if the stock pulls back toward the $55-57 support zone (roughly 11-14% downside) or if forward EPS estimates are revised upward, and would downgrade to Sell if revenue growth decelerates below 10% or if the profit decline materializes. Valuation verdict: fairly valued relative to history and peers, with the 1.86x PS near the low end of its range but the 24.33x trailing PE in the upper-middle, reflecting depressed trailing earnings rather than an extreme valuation.
Sign up to view all
OXY 12-Month Price Forecast
The forward-looking view is balanced: OXY's balance-sheet repair and cash generation are real, but the stock has already priced in much of the good news after a 49.65% one-year rally. The key tension is whether the 12.8x forward PE is a genuine value opportunity or a reflection of optimistic consensus EPS that will be revised down given the anticipated 32% profit decline. Analyst sentiment is constructive (26 analysts, mean 2.19, average target $70.54), but the modest 9.9% upside and the $60 low target below the current price suggest limited margin of safety. I would upgrade to bullish if forward EPS estimates are revised upward or if the stock pulls back to the $55-57 support zone, and downgrade to bearish if oil prices fall below $60/bbl or if Q3 earnings miss.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Occidental Petroleum's 12-month outlook, with a consensus price target around $70.74 and implied upside of +12.8% versus the current price.
Average Target
$70.74
0 analysts
Implied Upside
+12.8%
vs. current price
Analyst Count
—
covering this stock
Price Range
$60 - $82
Analyst target range
Coverage is deep, with 26 analysts and a consensus recommendation of "buy" (mean rating 2.19 on a scale where lower is more bullish). The average target price of $70.54 implies roughly 9.9% upside from the current $64.17, a moderate rather than aggressive bullish stance that reflects how much of the re-rating has already occurred. Consensus EPS estimates of $5.23 (range $4.72-$5.73) on average revenue of $25.99 billion underpin that target, and the bullish tilt is corroborated by recent institutional actions: Wells Fargo, Barclays, Evercore ISI, Susquehanna, and Stephens all maintain Overweight/Outperform/Positive ratings, while UBS, Citigroup, and Truist sit at Neutral/Hold. The target range of $60.00 to $82.00 is moderately wide, spanning about 34% from low to high, which signals meaningful disagreement about the oil-price path and the earnings durability implied by the 12.8x forward PE. The $82 high target likely assumes firmer crude prices, successful debt reduction from the chemicals sale, and multiple expansion toward historical mid-cycle levels, while the $60 low target (below the current price) prices in margin compression and the anticipated profit decline. Notably, no firm has issued a downgrade in the visible ratings history, and the July 2026 double upgrade from underperform to outperform was a clear positive inflection; the absence of Sell ratings and the clustering of targets above $60 suggest conviction leans constructive, though the modest average upside argues the easy money has been made.
Bulls vs Bears: OXY Investment Factors
The bull case currently has stronger evidence, anchored by accelerating revenue growth of 31.82% YoY, meaningful debt reduction from the $9.7 billion chemicals sale, and a forward PE of 12.8x that looks undemanding for a producer with 4.6 billion boe of reserves. However, the bear case is credible: Zacks' expected 32% profit decline next year directly challenges the forward earnings optimism embedded in the valuation, and trailing margins of 10.97% net and 17.24% operating reveal how much of recent profitability depends on one-time gains and commodity prices. The single most important tension is whether the forward EPS estimate of $5.23 is achievable or whether the anticipated profit decline forces a sharp downward revision—this factor alone would most change the thesis, as it determines whether 12.8x forward PE is a value opportunity or a value trap. Technical momentum and analyst sentiment lean constructive, but the modest 9.9% average target upside suggests the easy money has been made.
Bullish
- Revenue accelerating at 31.8% YoY: Q2 2026 revenue of $8.327 billion grew 31.82% year-over-year and accelerated sequentially from $5.230 billion in Q1 2026 and $5.013 billion in Q4 2025. This sharp top-line inflection demonstrates strong operational momentum and commodity leverage.
- Deleveraging from $9.7B chemicals sale: The sale of the chemicals unit to Berkshire for roughly $9.7 billion is being used to pay down debt, with $1.792 billion repaid in Q2 2026 alone. Debt-to-equity has fallen to 0.665 from 0.79 in Q4 2024, materially reducing balance-sheet risk.
- Attractive forward valuation at 12.8x: Forward PE of 12.80x represents a 47% compression from the trailing 24.33x, implying the market expects earnings to nearly double. The 1.11x price-to-book sits near the low end of its multi-year 1.1-2.1x range, suggesting value.
- Strong technical momentum and relative strength: OXY is up 49.65% over the past year and 51.42% YTD, massively outperforming the S&P 500's 13.13% and 11.45% gains. Relative strength versus SPY is +36.52% over one year and +12.89% over one month, with the stock at 95% of its 52-week range.
Bearish
- Expected 32% profit decline next year: Zacks flags an expected 32% profit drop next year, which directly contradicts the 12.8x forward PE that implies earnings nearly doubling. This creates significant risk of downward estimate revisions and multiple compression.
- Earnings quality heavily reliant on one-time items: Q1 2026 net income of $3.345 billion was inflated by a large non-operating gain on just $375 million of operating income, producing a 63.96% net margin. Trailing net margin is only 10.97% and operating margin 17.24%, highlighting volatile underlying profitability.
- Commodity concentration and cyclical revenue: Oil and gas dominates the mix at $10.21 billion versus just $612 million from midstream, and the pending chemicals divestiture will further concentrate revenue in E&P. Revenue is highly sensitive to hydrocarbon realizations and Middle East geopolitics.
- Tight liquidity with current ratio below 1.0: The current ratio of 0.936 signals potential near-term liquidity constraints, and ROE of 6.57% and ROA of 4.68% remain modest for the sector. The 67.3% dividend payout ratio limits financial flexibility.
OXY Technical Analysis
OXY is in a sustained uptrend, with the stock up 49.65% over the past year and 51.42% year-to-date, decisively outperforming the S&P 500's 13.13% and 11.45% respective gains. At $64.17, the shares sit at roughly 95% of the 52-week range (low $38.80, high $67.45), a positioning that signals strong momentum but also leaves limited headroom before overhead resistance and raises the risk of overextension after such a steep run. The 27.63% max drawdown over the period underscores that this has been a volatile climb rather than a smooth one. Recent momentum is accelerating rather than fading: the stock is up 11.87% over the past month and 11.99% over three months, with the 1-month gain actually outpacing the 3-month figure, indicating the pace of appreciation has picked up. Relative strength versus SPY is strongly positive across every window (+12.89% over 1 month, +9.14% over 3 months, +36.52% over 1 year), and the latest session added 2.67% on elevated volume of 11.64 million shares, confirming buyers are in control. The 6-month change of 12.34% versus the 1-year 49.65% shows most of the annual gain was front-loaded, but the renewed 1-month thrust suggests a second leg higher rather than a fading trend. Key resistance sits at the 52-week high of $67.45, roughly 5.1% above the current price; a clean breakout would confirm the uptrend and likely invite momentum buyers, while failure there could cap the advance. Support is anchored at the $38.80 52-week low, though nearer-term support likely sits around the $55-57 zone where the stock consolidated in September; a break below that would signal a trend reversal. Notably, the reported beta of 0.245 implies the stock has historically moved with only about a quarter of the market's volatility, an unusually low reading for an E&P name that argues for smaller position-sizing adjustments than a typical high-beta energy stock would require, even as the 27.63% drawdown shows idiosyncratic and commodity-driven risk remains material.
Beta
0.24
0.24x market volatility
Max Drawdown
-27.6%
Largest decline past year
52-Week Range
$39-$67
Price range past year
Annual Return
+48.3%
Cumulative gain past year
| Period | OXY Return | S&P 500 |
|---|---|---|
| 1m | +10.3% | -0.2% |
| 3m | +12.0% | +5.5% |
| 6m | +3.5% | +7.1% |
| 1y | +48.3% | +12.3% |
| ytd | +48.0% | +12.9% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
OXY Fundamental Analysis
Revenue has inflected sharply higher: Q2 2026 revenue of $8.327 billion grew 31.82% year-over-year versus $6.317 billion in Q2 2025, and marked a strong sequential acceleration from Q1 2026's $5.230 billion and Q4 2025's $5.013 billion. The oil and gas segment dominates the mix at $10.21 billion versus just $612 million from midstream, so the top-line swing is overwhelmingly a function of hydrocarbon realizations and volumes rather than diversification. The trajectory implies the investment case is highly commodity-levered: growth is real and accelerating, but it is cyclical rather than secular, and the pending chemicals divestiture will further concentrate revenue in E&P. Profitability is robust at the operating line but noisy below it: Q2 2026 net income was $2.977 billion on a 35.75% net margin, with gross margin of 81.03% and operating margin of 45.41%, though the prior quarter's 63.96% net margin was inflated by a large non-operating gain (net income of $3.345 billion on just $375 million of operating income). The trailing figures are less flattering, with a 10.97% net margin and 17.24% operating margin reflecting the weaker Q4 2025 (net income of $102 million) and Q1 2026 operating compression. Margins are therefore expanding sharply off a cyclical trough, but the gap between quarterly and trailing profitability warns that earnings quality depends heavily on one-time items and commodity prices. The balance sheet is improving: debt-to-equity stands at 0.665 (down from 0.79 in Q4 2024), the current ratio is 0.936, and TTM free cash flow is $5.312 billion against Q2 2026 FCF of $2.707 billion, comfortably covering the $430 million quarterly dividend. ROE of 6.57% and ROA of 4.68% remain modest for the sector, and the sub-1.0 current ratio signals tight near-term liquidity, but aggressive debt repayment ($1.792 billion in Q2 2026 alone) and a 3.97% dividend yield with a 67.3% payout ratio point to a company prioritizing deleveraging over growth capex.
Quarterly Revenue
$8.3B
2026-06
Revenue YoY Growth
+31.8%
YoY Comparison
Gross Margin
81.0%
Latest Quarter
Free Cash Flow
$5.3B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is OXY Overvalued?
Because net income is positive, the PE ratio is the primary metric: OXY trades at a trailing PE of 24.33x but a forward PE of just 12.80x, a roughly 47% compression that implies the market expects earnings to nearly double. That gap is the crux of the valuation debate, and it sits awkwardly against the Zacks-flagged expectation of a 32% profit decline next year, suggesting consensus forward estimates may be optimistic or that the trailing figure is depressed by one-off charges. On peer comparison, the 1.86x PS and 1.11x PB are modest in absolute terms, but the 5.37x EV/EBITDA and 3.42x EV/Sales are mid-range for large-cap E&P, and with no explicit industry-average multiples provided in the valuation data, a precise premium/discount spread cannot be quantified; qualitatively, a 1.11x book multiple and 12.8x forward earnings are not demanding for a producer with 4.6 billion boe of reserves, though the negative PEG ratio of -0.70 reflects the earnings volatility that complicates growth-adjusted comparisons. Historically, OXY's own PE has ranged from roughly 2.9x in Q1 2022 to over 38x in Q2 2025, and its PS ratio has spanned roughly 3.5x to 12.1x; the current 1.86x PS sits near the low end of that band while the 24.33x trailing PE sits in the upper-middle, a mixed signal that reflects depressed trailing earnings rather than an extreme valuation. The 3.97% dividend yield is well above the 0.6-1.0% yields seen through 2022-2025, reinforcing that the stock is priced for cash return rather than growth, and the 1.11x PB near the bottom of its multi-year 1.1-2.1x range suggests either a value opportunity or lingering skepticism about balance-sheet risk.
PE
24.3x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 3x~22x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
5.4x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks center on earnings quality and commodity concentration. Q1 2026 net income of $3.345 billion was inflated by a large non-operating gain on just $375 million of operating income, and Q4 2025 net income was only $102 million, showing extreme quarterly volatility. The current ratio of 0.936 is below 1.0, signaling tight near-term liquidity, while the 67.3% dividend payout ratio and $430 million quarterly dividend commitment limit financial flexibility. With oil and gas representing $10.21 billion of the $10.82 billion segment mix, revenue is overwhelmingly tied to hydrocarbon realizations, and the pending chemicals divestiture will further concentrate this exposure.
Market and competitive risks include valuation compression and commodity-price sensitivity. The trailing PE of 24.33x sits in the upper-middle of its historical range (2.9x to over 38x), and the negative PEG ratio of -0.70 reflects earnings volatility that complicates growth-adjusted comparisons. Zacks' expectation of a 32% profit decline next year directly threatens the 12.8x forward PE, which implies earnings nearly doubling; any downward revision to the $5.23 consensus EPS would pressure the multiple. The reported beta of 0.245 suggests low market correlation, but the 27.63% max drawdown over the past year demonstrates that idiosyncratic and commodity-driven risk remains material. Middle East geopolitical developments, as highlighted in recent news, can swing oil prices and OXY's earnings.
Worst-case scenario: a sharp decline in oil prices combined with a failure to achieve the forward earnings estimate would trigger a double hit of lower EPS and multiple compression. If the stock retraces to its 52-week low of $38.80, investors would lose approximately 39.5% from the current $64.17. The analyst low target of $60.00 implies a more modest 6.5% downside, but that likely assumes stable crude prices; a commodity downturn could push the stock below the low target toward the 52-week low. The 27.63% max drawdown over the past year provides a recent precedent for the magnitude of loss possible in an adverse scenario.
FAQ
The most severe risk is commodity price exposure: oil and gas represent $10.21 billion of the $10.82 billion segment mix, and a decline in oil prices below $60/bbl would hit revenue and earnings, potentially driving the stock toward the 52-week low of $38.80 (a 39.5% loss). Second is earnings quality risk: Q1 2026 net income of $3.345 billion was inflated by a large non-operating gain on just $375 million of operating income, and trailing net margin is only 10.97%, showing that underlying profitability is volatile and dependent on one-time items. Third is valuation risk: the 12.8x forward PE implies earnings nearly doubling, but Zacks expects a 32% profit decline next year, creating risk of downward estimate revisions and multiple compression. Fourth is liquidity risk: the current ratio of 0.936 is below 1.0, signaling tight near-term liquidity, and the 67.3% dividend payout ratio limits financial flexibility. These risks are ranked from most to least severe, with commodity exposure being the dominant factor.
The 12-month forecast has three scenarios: a bull case (25% probability) targeting $75-82, driven by firm oil prices above $90/bbl, successful debt reduction, and a breakout above the 52-week high of $67.45; a base case (50% probability) targeting $65-75, assuming oil prices remain range-bound and earnings meet the $5.23 consensus EPS; and a bear case (25% probability) targeting $38.80-60, driven by a sharp oil price decline and the materialization of the expected 32% profit decline. The base case is most likely, with the key assumption being that WTI crude averages $70-80/bbl and OXY delivers earnings in line with consensus. The average analyst target of $70.54 falls within the base case range, corroborating this view. However, the wide target range ($60-$82) reflects significant disagreement about the oil-price path and earnings durability.
OXY appears fairly valued to slightly undervalued on some metrics and slightly overvalued on others. The forward PE of 12.80x is undemanding for a producer with 4.6 billion boe of reserves, and the 1.11x price-to-book sits near the low end of its multi-year 1.1-2.1x range, suggesting value. However, the trailing PE of 24.33x is in the upper-middle of its historical range (2.9x to over 38x), and the 1.86x PS ratio, while near the low end of its 3.5x-12.1x historical band, reflects depressed trailing earnings. The negative PEG ratio of -0.70 highlights earnings volatility. The market appears to be pricing in a recovery in earnings (hence the 12.8x forward PE), but the anticipated 32% profit decline next year suggests consensus estimates may be too optimistic. Overall, the stock is not expensive relative to its own history, but the valuation implies the market expects a significant earnings rebound that may not materialize.
From a risk/reward perspective, OXY is a moderate buy at best after its 49.65% one-year rally. The stock trades at $64.17 with only 9.9% upside to the average analyst target of $70.54, and the low target of $60.00 is below the current price, suggesting limited margin of safety. The forward PE of 12.80x looks attractive, but it implies earnings nearly doubling, which conflicts with Zacks' expected 32% profit decline next year. The biggest downside risk is a retest of the 52-week low of $38.80, representing a 39.5% loss. For income investors, the 3.97% dividend yield and $5.312 billion TTM free cash flow are compelling, but the 67.3% payout ratio limits flexibility. It is a good buy for long-term investors seeking oil exposure and dividend income, particularly on a pullback to the $55-57 support zone, but less attractive for short-term traders given the limited upside to targets.
OXY is better suited for long-term investment than short-term trading. The stock is in a mature growth stage with cyclical earnings, a 3.97% dividend yield, and a 67.3% payout ratio, making it attractive for income-oriented investors with a multi-year horizon. The reported beta of 0.245 suggests low market correlation, but the 27.63% max drawdown over the past year demonstrates significant idiosyncratic and commodity-driven volatility, which is better absorbed over a longer holding period. Earnings visibility is limited by commodity prices and the anticipated 32% profit decline next year, making short-term trading risky. A suggested minimum holding period is 2-3 years to ride out commodity cycles and benefit from debt reduction and dividend payments. Short-term traders may find opportunities around earnings announcements and oil-price movements, but the limited 9.9% upside to the average target reduces the risk/reward for short-term positions.